Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects.

@article{Graham2008EarlyTC,
  title={Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects.},
  author={Karen A. Graham and Hyunsoon Cho and Kimberly A. Brownley and Joyce B. Harp},
  journal={Schizophrenia research},
  year={2008},
  volume={101 1-3},
  pages={287-94}
}
OBJECTIVE To examine prospective changes in cardiovascular disease (CVD) and type-2 diabetes risk factors in young adult first episode psychotic (FEP) patients treated with second generation antipsychotic medications. METHODS At baseline, fasting serum and anthropometric measures were obtained from 45 FEP patients and 41 healthy adults (controls) of similar age, ethnicity and sex; sixteen of the FEP patients remained on the same antipsychotic medication and were available for a second blood… CONTINUE READING